Polio Special Part 4 : Poisonous vaccines

[Guest guest]

http://www.theecologist.org/archive_article.html?article=459 & category=76

 

 

Polio Special Part 4 : Poisonous vaccines

 

 

Date Published: 01/05/2004

Author: Janine Roberts

 

`If you continue to allow these contaminated [polio] vaccines to go out, I

guarantee you that over the next 20 years you will have epidemics of cancer

unlike the world has ever seen'. Bernice Eddy's testimony to the U.S. Congress

in 1972.

Poisonous vaccines

 

The 1950's race to be the first with a polio vaccine was led by Jonas Salk and

Albert Sabin. Both designed polio vaccines intended to make people immune by

exposing them to millions of polio virus. Both would be administered in multiple

doses to several hundred million children.

 

Making so much vaccine required a vast amount of polio virus. There was a fierce

debate over what kind of cell to grow this virus in. Some advocated breeding it

in fertilized chicken eggs, others in human placental cells grown in laboratory

vessels, and others in dishes containing the cells of wild-caught monkeys. Salk

and Sabin decided to use monkeys, since they could provide large organs on which

the virus would grow readily, and would be a few pence cheaper than the

alternatives.

 

Salk and Sabin must have known that monkey viruses were a serious danger. Sabin

had lost a colleague to a monkey virus (Simian Virus B) during vaccine-related

research in 1932. And, Dr Herald R Cox, the Principal Bacteriologist of the

United States Public Health Service, had forbidden his scientists from using

monkeys to make a polio vaccine because of the danger monkey virus represented.

 

Nonetheless Salk and Sabin pressed on with monkeys. They both selected the

rhesus monkey found in the temples of northern India. They used their kidneys,

since these are large and easy to remove and their testicles, since these are

even easier to extract. They calculated they could grow enough viruses on a

single kidney to make around 6,000 doses of the vaccine - enough for 2,000

children at 3 doses each. In 1955 this meant they required the kidneys of some

47,710 monkeys for the US - and some 8,000 for the UK vaccine.(1)

 

The monkeys were flown via London to the US. On average, half of the monkeys

died on route or were rejected as too infected or ill to use on arrival. But

some two million wild-caught monkeys arrived in good enough shape to be killed

in the West for polio vaccine production and testing over the next decades.

 

 

In 1955, the UK adopted the Salk vaccine against the recommendation of its local

manufacturer, Wellcome, which wanted instead to use a vaccine it thought safer

as it was not grown in monkeys but in fertilized chicken eggs. Sweden and Canada

would also refuse to use monkey cells - instead they grew their vaccines' polio

virus on human cells multiplied in laboratories.

 

In 1954, the scientist in charge of the US government's safety testing

laboratory, Bernice Eddy, made a shocking discovery. Her monkeys, after being

dosed with the monkey kidney preparation, had collapsed and died. This should

have been the end for the Salk vaccine - but astonishingly it wasn't. Instead,

Eddy was silenced by her employer, the federal National Institutes of Health.

 

Eddy continued to worry. In 1959 she took matters into her own hands. She went

back unauthorised to put the Salk polio vaccine through more tests. She was

horrified to find that, when she injected its growth medium into 23 hamsters, 20

of them grew large cancer tumours. She investigated further and found the Salk

preparation had infected the hamsters with a monkey virus. This would be named

Simian Virus 40 (SV40) as it was the 40th monkey virus discovered. Again her

boss would react with fury, and ordered her to remain silent. This time she

didn't. In 1960, at a meeting of the New York Cancer Society, she told them what

happened when she had tested the Salk vaccine. She was immediately demoted by

the National Institutes of Health. They took her laboratory from her and delayed

publication of her research.

 

Meanwhile the Salk vaccine was proving ineffective. Children vaccinated with it

were still coming down in hundreds with polio. The Journal of the American

Medical Association would carry an article admitting, `It is now generally

recognised that much of the Salk vaccine used in the US has been worthless.' (2)

By 1959, preparations had begun to replace it with its main rival, the Sabin

oral vaccine.

 

 

Behind the scenes, news of Eddy's unauthorised research had reached Merck,

Sharpe and Dohme, who were then manufacturing both the Salk and Sabin vaccine.

They put two scientists, Ben Sweet and Maurice Hilleman, on to checking to see

if her research on the Salk vaccine also applied to the Sabin. They found it

did. In a 1960 paper they reported the `Sabin live polio virus vaccine was

contaminated' and `SV40 has oncogenic [cancer-causing] properties in hamsters.'

They added that this `raises the important question of the existence of other

such viruses.'

 

Asked many years later why they had not warned the public, Hilleman replied;

`Because you could start a panic. They had already had production problems with

[vaccinated] people getting polio. If you added to that the fact that they found

live [monkey] virus in the vaccine, there would have been hysteria.'

 

But their reports led the giant Merck Corporation to decide that both the Salk

and the Sabin vaccines were much too dangerous for it to continue to make them.

And despite being begged by the US Surgeon General to continue, they declined,

writing in December 1960 , `having again reviewed our decision in the light of

your letter... Our scientific staff have emphasized to us that there are a

number of serious scientific and technical problems that must be solved before

we could engage in large-scale production of live poliovirus vaccine. Most

important among these is the problem of extraneous contaminating simian viruses

that may be extremely difficult to eliminate and which may be difficult if not

impossible to detect at the present stage of the technology.' (3) But again none

of this disquiet was made public. This letter and decision would only be

disclosed some thirty years later through a legal action brought by the parents

of an allegedly vaccine-damaged child.

 

The implication of what Merck said to the Surgeon General was that both the Salk

and Sabin polio vaccines had been released and given to children by the million

despite their manufacturers being unable to remove from them their monkey virus

contamination. Whilst Merck honourably withdrew from doing this, other companies

would irresponsibly continue. The UK and US Health Departments, and the World

Health Organisation, likewise irresponsibly continued to endorse the safety of

these vaccines, which were known to be contaminated.

 

Privately, among the scientists involved, a joke circulated. The Sabin vaccine

had just been tested on some 80 million Soviet citizens. The joke was that they

had made sure the Russians would not be able to compete at the coming Olympics -

as they would be riddled with cancers! (4)

 

The Merck letter did not lead to the health authorities withdrawing the polio

vaccines. They continued to distribute them until, in 1961, a doctor in

Scotland, who presumably had read Sweet and Hilleman's report, decided to test

the children to whom he had just administered the Salk vaccine.(5) He was

shocked to find that half the children were contaminated with SV40. He

immediately reported this to the Lancet medical journal.

 

This exposure led to instant but secret action. The authorities in the US and UK

stopped distributing the Salk vaccine and replaced it with the Sabin vaccine.

But none of the contaminated vaccine distributed was to be withdrawn. The

authorities didn't want to alarm the public. It would take two years before all

the contaminated stocks of Salk vaccine were exhausted.

 

 

In self-defence the US health authorities have since repeatedly claimed that the

measures they took in March 1961 ensured that the polio vaccine was totally

clear of SV40 from then on.(6) But this would be exposed as a lie when the

private correspondence between government and vaccine manufacturers became

public in the course of litigation by parents.

 

In 1961, the government's man in charge of vaccine safety, a Dr Murray, secretly

authorised Lederle Inc (the major Sabin polio vaccine maufacturer in the US) to

use SV40 contaminated vaccine.(7) On top of this, the same internal memo

revealed that the company was not only using the SV40-free African Green Monkeys

to make the vaccine but was `harvesting kidneys' from a monkey species from the

Philippines, the carcopithecus, that did carry SV40.

 

And another memo forced out into the open revealed that Lederle had totally

ignored the FDA regulation that bound manufacturers to ensure `each seed virus

used in the manufacture shall be demonstrated to be free of extraneous microbial

agents'. Lederle had not even bothered to check to see if they were. This was

supported in a US government memo, which recorded; `It should be made clear that

Lederle did not test the original Sabin seeds for extraneous agents or

neurovirulence'.(8)

 

In 1976, with the withdrawal of Pfizer, Lederle became the only manufacturer of

the Sabin vaccine in the US, and that same year, researchers at the US Bureau of

Biologics found its polio vaccine contained between 1,000 and 100,000 simian

viruses per millilitre of vaccine.

 

In 1978, John Martin, Director of the Viral Oncology Laboratory at the US

government's Bureau of Biologics inspected the samples of polio vaccine held at

his lab. He reported: `There was a lot of extraneous DNA in the vaccine'.(9) But

he was told to do nothing about it, since a protest might cause Lederle to stop

production and `vaccine manufacturing was an essential component of industry,

this country's protection against potential biological warfare'. John Martin

would later discover in damaged human brain cells another monkey virus, SCMV. He

found this was from the African Green Monkey, the same species that are

currently used to make the polio vaccine. Thus monkey viruses and DNA fragments

continued to be administered to hundreds of million of children under the guise

of the polio vaccine.

 

The consequences are now coming out in scores of scientific papers. The first

human cancers containing SV40 were discovered around 1970. One of these was that

of Mark Moreno. He had a large brain tumour removed in 1970, and has since had

several operations. His tumour was riddled with SV40. (He is currently suing for

compensation.) Many similar cases have since been found.

 

Yet in 1988 the UK Health Minister would assure Parliament that, although the

polio vaccine was once contaminated with SV40, American research had showed SV40

to be harmless.

 

 

Is the Current Polio Vaccine Safe?

 

Michael Steward, Professor of Immunology at the London School for Hygiene and

Tropical Medicine, headed a team working on new vaccines, so I asked him about

children who fell severely ill shortly after taking vaccines based on living

viruses. One of my questions was: `Could their parents possibly be right in

suspecting the vaccine?' His reply was: `What else would you expect?' I

expressed surprise. He continued, `We all know the current living viral vaccines

are dangerous - that is why I am heading a team to try to develop safer

vaccines.' (10)

 

Quite simply we still do not have the technology available to completely purify

these vaccines; at least at a price the manufacturers are willing to pay. WHO

instead has set a `recommended' level for maximum vaccine contamination. It

recommended in the mid 1990s that `the amount of cellular DNA [contaminating]

biological products should be limited to 100 picagrams [100,000 billionths of a

gram] per dose'.(11)

 

This limit however seemingly proved `unrealistically low'. So the recommended

maximum was increased ten thousand fold to 10 nanograms (ten billionths of a

gram). However, a safety-supervising scientist admitted in 1999 that `for live

viral vaccines, ... it may not be possible to limit the total amount of DNA to

ten nanograms'. In case this level of contamination seems inconsequential, I

believe ten nanograms is greater than the approximate weight of 250 million

polioviruses or 200 million SV40. The seriousness of this level of contamination

is still undetermined, but it has been noted that the presence of a single SV40

virus, or a piece of free DNA, in a cell, may suffice for that cell to be

damaged, and possibly made cancerous.

 

And we still do not know what effect this vaccine cocktail of monkey viruses,

DNA debris, nanobacteria and toxins, and the possible resultant re-combinations

and mutations of viruses, has had on the some four billion children to which the

contaminated polio vaccine has been given in repeated doses through their most

vulnerable years.

 

The evidence seems to lead to the inescapable conclusion that the polio vaccine

has been an unmitigated disaster. It was made to stop epidemics of infantile

paralysis but they are still happening, and mistakenly tried to do so by

targeting a virus that, given the evidence, is most likely never to have been

the principal cause of this disease. Instead it has spread monkey viruses and

other contaminants around the world, perhaps causing far more serious illness

than the poliovirus ever did.

 

At the root of this disaster as always, lies money. The drug companies made the

choice for the UK and much of the rest of the world. They chose to continue to

use monkey kidneys instead of safer cells since it was for them a few pennies

cheaper a dose, despite knowing that these kidneys carried monkey viruses into

the vaccine, despite knowing from early on that at least one of these was linked

to cancers. They have thus knowingly and dangerously contaminated our children -

and, tragically, are still doing so.

 

 

 

Making the vaccine

 

To mass vaccinate, the vaccine scientists had to produce a stable `seed-stock'

of poliovirus from which they could breed the huge amounts of virus needed for

the vaccine. The process they used was crude and very liable to viral

contamination.

They made a suspension in water of diseased spinal tissue from polio victims,

and injected this into the living brains of monkeys. They believed that the more

times they repeated this the larger, more stable and purer the seed-stock of

polioviruses produced for the vaccine would become.

 

Salk thus injected the diseased tissue into the brains of 14 monkeys one after

the other. Each time he would extract fluid from the infected brain and then

re-inject this into another. Finally he poured the virus-rich fluid from the

last monkey into a vessel containing minced monkey testicles. The viruses grew

in number.

 

The fluid from this was then poured onto more testicles where the virus

multiplied further. This viral-rich fluid was then filtered, spun and roughly

purified, before being put into bottles labelled as the Salk vaccine seed.

 

Salk then sent his patented vaccine `seed' to various manufacturers where it

would be mixed with vast quantities of minced monkey kidney on which the virus

would multiply a million-fold - before being killed by poisoning with

formaldehyde prior to being put into bottles of his vaccine. Six manufacturers

would thus make up 27 million doses of his vaccine in 1955, in absolute

confidence that it would be officially approved.

 

 

 

SABINS OPV

 

As Sabin wanted to use a `live' polio virus, he needed to weaken or `attentuate'

the virus, in much the same way as one could weaken a plant if it were rapidly

and repeatedly moved from one type of soil to another.

 

Hence, the poliovirus was weakened by mutation, brought about through rapidly

transplanting it up to 51 times from one lot of monkey kidneys to another. It

was also weakened by having to adjust to growing in different species of monkey

cells. Both Indian Rhesus and African Green monkeys cells were employed - thus

giving the vaccine `seed' every opportunity to become contaminated with

incompatible viruses from two continents before being bottled as the patented

`Sabin Original Merck' polio virus seed lot. This was `safety tested' by being

injected into the brains of about one hundred chimpanzees.

 

A leading scientist, Leonard Hayflick, wrote in 1958: `Monkey kidneys were

notorious for their content of unwanted viruses, potentially dangerous viruses.'

He said the Sabin vaccine was grown on `constantly contaminated monkey kidneys.'

Joshua Lederberg of Stanford University would warn `crude virus preparations,

such as those in common use at the present time, are vulnerable to frightful

mishaps of contamination and misidentification.'

 

We now know the polio virus seed lots they produced were a virtual maelstrom of

monkey and human viruses, all circulating among great numbers of DNA fragments

and much cellular debris, all potentially highly dangerous. This was inevitable,

given Salk and Sabin's choice of production methods and the technology available

to them.

 

 

 

The case against SV40

 

In 1988, a review of a study conducted between 1959 and 1965 on 58,807 pregnant

women12, discovered that the risk of brain tumours among offspring of mothers

who had received the Salk vaccine was 13 times higher than the risk among

offspring of mothers who had not. The conclusion was that the cancers were

probably caused by a still-unidentified infection originating in the polio

vaccine, which (according to the reviewers) was known to have been contaminated

with numerous simian viruses.(13)

 

Also in 1988, Michele Carbone, a researcher in Chicago, found SV40 in around 85

per cent of the cancers associated with asbestos. It appeared to make this toxin

more dangerous. He found it switches off a key human gene, the p53, which helps

to protect us from cancers.

 

In 1997 I attended a National Institutes of Health emergency workshop in

Washington called, because laboratories worldwide had found SV40 in over 33 per

cent of all the human bone cancers tested and in over 85 per cent of the

childhood brain tumours. The FDA that same year also reported: `The discovery in

1960 that a DNA tumour [carcinogenic] virus, designated simian virus 40 (SV40),

was an inadvertent contaminant of rhesus monkey cells...it confronted the

scientific and regulatory community with the very problem that they had sought

to avoid in vaccine development...' (14)

Late in 1999 an extensive study in China reinforced those results. It found SV40

in common brain tumors among children. It also found the virus in 33 to 90 per

cent of five other kinds of brain tumour examined.(15)

 

In 1998 SV40 was found for the first time in English cancers. At that time no

laboratory in England was equipped for such a search. It was only found because

I went looking for it with colleagues while working on a documentary for Channel

4's Dispatches. Our team used a laboratory in Italy to test about 20 cancer

samples from English patients. We found SV40 present in a bone cancer and in a

terminal case of mesothelioma.

 

Two very recent studies, from Finland and Turkey, found no SV40 in domestic

mesothelioma (cancer caused by asbestos) samples but did find it in American and

Italian samples. Neither Turkey nor Finland used SV40-contaminated vaccines,

while Italy and the US did. Today Finland has one of the lowest rates of

mesothelioma in the Western world.

 

In the last few years SV40 has been linked to more and more cancers, such as

Non-Hodkin's lymphoma, the fifth most common cancer in the US and one that has

been rapidly increasing since the contaminated polio vaccine was released.

 

A recent German study found that if one put SV40 into lactating female rats they

all got breast cancer, (as did 70 per cent of the non-lactating) but the SV40

did not stay in the tumours it helped create. Could this explain the growth in

human breast cancer? (16)

 

NIH researcher Dr. Jeffery Kopp has also uncovered a link between SV 40 and a

new and deadly form of kidney disease. Prior to 1980 so-called `collapsing'

renal disease was unknown. Since that time, however, it has been rapidly

increasing. Fully 60 per cent of those with the new, virulent `collapsing

variety' showed evidence of SV 40.

 

It seems from all the research that SV40 is dangerous because it is badly

adjusted to living in us, perhaps because it only recently infected humans and

has not yet adapted to us. It attaches to our cells in such a way that it

disables two key immune system defences. It also damages our chromosomes by

adding or deleting whole sections. Once inside a cell, Joseph Testa reported,

`it looks as if somebody set off a bomb inside the cell's nucleus.'

 

 

 

 

 

SBC - Internet access at a great low price.